U.S. markets closed

Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ?P=002603.SZ)

Shenzhen - Shenzhen Delayed Price. Currency in CNY
Add to watchlist
27.71-1.14 (-3.95%)
At close: 03:04PM CST

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

No. 238 Tianshan Street
High-tech Industrial Development Zone
Shijiazhuang
China
86 311 8590 1311
http://www.yiling.cn

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees16,912

Key Executives

NameTitlePayExercisedYear Born
Mr. Xiang Jun WuGen. Mang. and DirectorN/AN/A1975
Dr. Feng Xiang DaiCFO & Deputy GMN/AN/A1965
Mr. Xiu Qiang GaoSupply Center DirectorN/AN/A1966
Ms. Rui WuDeputy GM, Sec. of the Board & Non-Independent DirectorN/AN/A1980
Mr. Shao Hua ZhaoDeputy Gen. Mang.N/AN/A1966
Ms. Yue Zhi HanProduction Management Committee Director and Deputy Gen. Mang.N/AN/A1966
Ms. Qiu Lian ZhangDeputy GM & Non-Independent DirectorN/AN/A1970
Mr. Wei Dong XuDirector of HR and DirectorN/AN/A1968
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceuticals primarily in China. It operates through three segments: Modern Chinese Medicine, Chemical Pharmaceutical, and Health Industry. The company offers drugs for cardiac and cerebral blood disease, influenza and respiratory disease, tumor, and diabetes mellitus. It sells its products through physical display, online product distribution, and join distribution parallels. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.

Corporate Governance

Shijiazhuang Yiling Pharmaceutical Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.